- Home
- BWAY vs HRZN Comparison
BWAY vs HRZN Comparison
Compare BWAY & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- HRZN
- Stock Information
- Founded
- BWAY 2003
- HRZN 2008
- Country
- BWAY Israel
- HRZN United States
- Employees
- BWAY N/A
- HRZN N/A
- Industry
- BWAY Medical/Dental Instruments
- HRZN Finance/Investors Services
- Sector
- BWAY Health Care
- HRZN Finance
- Exchange
- BWAY Nasdaq
- HRZN Nasdaq
- Market Cap
- BWAY 280.7M
- HRZN 264.2M
- IPO Year
- BWAY 2019
- HRZN 2010
- Fundamental
- Price
- BWAY $15.02
- HRZN $6.12
- Analyst Decision
- BWAY Strong Buy
- HRZN Hold
- Analyst Count
- BWAY 2
- HRZN 4
- Target Price
- BWAY $18.00
- HRZN $7.81
- AVG Volume (30 Days)
- BWAY 61.1K
- HRZN 734.0K
- Earning Date
- BWAY 11-11-2025
- HRZN 10-28-2025
- Dividend Yield
- BWAY N/A
- HRZN 21.15%
- EPS Growth
- BWAY 679.98
- HRZN N/A
- EPS
- BWAY 0.11
- HRZN N/A
- Revenue
- BWAY $46,084,000.00
- HRZN $97,144,000.00
- Revenue This Year
- BWAY $335.63
- HRZN N/A
- Revenue Next Year
- BWAY $22.10
- HRZN $9.61
- P/E Ratio
- BWAY $55.30
- HRZN N/A
- Revenue Growth
- BWAY 26.50
- HRZN N/A
- 52 Week Low
- BWAY $7.84
- HRZN $5.97
- 52 Week High
- BWAY $17.00
- HRZN $10.69
- Technical
- Relative Strength Index (RSI)
- BWAY 48.22
- HRZN 29.87
- Support Level
- BWAY $14.65
- HRZN $5.97
- Resistance Level
- BWAY $15.60
- HRZN $6.33
- Average True Range (ATR)
- BWAY 0.67
- HRZN 0.17
- MACD
- BWAY -0.11
- HRZN 0.01
- Stochastic Oscillator
- BWAY 29.79
- HRZN 19.87
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.